Compare Pfizer Inc (PFE) vs Rush Street Interactive Inc (RSI) Price & Performance

Pfizer (PFE) trades at $24.83, up 0.32% today, with a neutral technical signal and bearish moving averages. The company reported revenue of $62.58B in 2025, with a net income margin of 11.83%, and has beaten EPS estimates for the last three quarters. Recent news highlights pipeline developments in oncology and obesity, with a consensus analyst price target of $28.25.

PFE offers a stable dividend and trades below analyst targets, but faces headwinds from patent expirations and volatile cash flows. The stock presents value with a P/E of 19.04, though growth depends on successful drug launches and navigating post-COVID revenue normalization.

Rush Street Interactive (RSI) trades at $34.52, up 6.22% in 24 hours, with strong bullish momentum from technical indicators and recent earnings beats. The stock shows robust revenue growth, reaching $1.13B in 2025, and maintains a 76.92% buy rating from analysts. Positive sentiment is fueled by expansion news, such as the BetRivers launch in Alberta (GlobeNewsWire, 2026-07-13).

Outlook remains positive with earnings growth as a key catalyst, though high valuation multiples (P/E 101.53) and overbought RSI levels pose risks. The consensus price target of $31.11 suggests potential downside, but institutional bullishness and operational cash flow strength support long-term upside if execution continues.